A2A Adenosine Receptor (A2AAR) as a Therapeutic Target in Diabetic Retinopathy

Ahmed S. Ibrahim(Wayne State University), Gregory I. Liou(Augusta University)
American Journal Of Pathology
April 24, 2011
10.1016/j.ajpath.2011.01.018
Cited by 55

Related Papers

Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes
|American Journal Of Pathology|2006|271
A lipidomic screen of hyperglycemia-treated HRECs links 12/15-Lipoxygenase to microvascular dysfunction during diabetic retinopathy via NADPH oxidase
|Journal of Lipid Research|2015|74
Glyceraldehyde-3-phosphate dehydrogenase/1,3-bisphosphoglycerate-NADH as key determinants in controlling human retinal endothelial cellular functions: Insights from glycolytic screening
|Journal of Biological Chemistry|2025|1